Adrenergic agonist

Results: 137



#Item
11

PK and PD Modeling Supports Development of MN-221, a Novel Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Exacerbations of COPD Kazuko Matsuda1, Kirk Johnson1, Alan W. Dunton1, Ernest Kitt1, Brian Sadle

Add to Reading List

Source URL: rosaandco.com

Language: English - Date: 2014-01-18 12:32:16
    12

    Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling and Simulation Support the Novelty of MN-221, a Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Asthma Brian M. Sadler, PhD2, Alan Dunton, MD1, Mari

    Add to Reading List

    Source URL: www.rosaandco.com

    Language: English - Date: 2014-01-18 12:32:56
      13

      Pharmacokinetics and Pharmacodynamics of MN-221, a Novel Highly-Selective Beta2-Adrenergic Agonist Administered to Chronic Obstructive Pulmonary Disease Patients Brian M. Sadler PhD, Alan Dunton MD, Ernest Kitt, James Bo

      Add to Reading List

      Source URL: www.rosaandco.com

      Language: English - Date: 2014-01-18 12:33:02
        14

        PK and PD Modeling and Simulation Support Development of MN-221, a Novel, Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Asthma Kazuko Matsuda1, Kirk Johnson1, Alan Dunton1, Maria Feldman1, Brian Sadler

        Add to Reading List

        Source URL: rosaandco.com

        Language: English - Date: 2014-01-18 12:32:11
          15

          Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling and Simulation Support the Novelty of MN-221, a Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Asthma Brian M. Sadler, PhD2, Alan Dunton, MD1, Mari

          Add to Reading List

          Source URL: rosaandco.com

          Language: English - Date: 2014-01-18 12:32:56
            16

            PK and PD Modeling Supports Development of MN-221, a Novel Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Exacerbations of COPD Kazuko Matsuda1, Kirk Johnson1, Alan W. Dunton1, Ernest Kitt1, Brian Sadle

            Add to Reading List

            Source URL: www.rosaandco.com

            Language: English - Date: 2014-01-18 12:32:16
              17

              Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling and Simulation Support the Novelty of MN-221, a Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Asthma Alan Dunton MD, Maria Feldman, Kazuko Matsuda

              Add to Reading List

              Source URL: www.rosaandco.com

              Language: English - Date: 2014-01-18 12:32:59
                18

                Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling and Simulation Support the Novelty of MN-221, a Highly-Selective Beta2-Adrenergic Agonist for Treatment of Acute Asthma Alan Dunton MD, Maria Feldman, Kazuko Matsuda

                Add to Reading List

                Source URL: rosaandco.com

                Language: English - Date: 2014-01-18 12:32:59
                  19Dosage forms / Asthma / Alcohols / Phenols / Salbutamol / Metered-dose inhaler / Adrenergic bronchodilator / Inhaler / Beta-adrenergic agonist / Pulmonology / Medicine / Respiratory therapy

                  PROVENTIL® HFA (albuterol sulfate) Inhalation Aerosol FOR ORAL INHALATION ONLY Prescribing Information DESCRIPTION

                  Add to Reading List

                  Source URL: www.merck.com

                  Language: English - Date: 2015-03-26 19:23:34
                  20Combination drugs / Phenols / Phenethylamines / Chronic lower respiratory diseases / Mometasone/formoterol / Formoterol / Salmeterol / Asthma / Beta2-adrenergic agonist / Pulmonology / Medicine / Respiratory therapy

                  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DULERA safely and effectively. See full prescribing information for DULERA. 

                  Add to Reading List

                  Source URL: www.merck.com

                  Language: English - Date: 2015-03-26 19:23:32
                  UPDATE